other material
confidence high
sentiment negative
materiality 0.65
CNS Pharmaceuticals ups ATM sales capacity to $43.5M from $30.2M; $23.75M raised so far
CNS Pharmaceuticals, Inc.
- Company increased aggregate sales price under A.G.P. Sales Agreement to $43.5M on March 20, 2025.
- Prior limit was $30.2M; remaining capacity before increase was $6.45M, now total unissued capacity ~$19.75M.
- As of March 20, 2025, 2,522,755 shares sold for gross proceeds of ~$23.75M; 2,944,381 shares outstanding.
- Shares sold under shelf registration S-3 (File 333-279285) that became effective May 17, 2024.